ATE284382T1 - Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23 - Google Patents

Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23

Info

Publication number: ATE284382T1
Authority: AT; Austria
Prior art keywords: inhibitor; production; acid derivative; hydroxamic acid; soluble human
Prior art date: 1999-10-27

Application number

AT00975954T

Other languages

English (en)

Inventor

Andrew S Faller

John Gerard Ward

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-27

Filing date

2000-10-25

Publication date

2004-12-15

2000-10-25 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2004-12-15 Application granted granted Critical

2004-12-15 Publication of ATE284382T1 publication Critical patent/ATE284382T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

AT00975954T 1999-10-27 2000-10-25 Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23 ATE284382T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9925470.8A GB9925470D0 (en)	1999-10-27	1999-10-27	Novel compounds
PCT/EP2000/010649 WO2001030747A1 (en)	1999-10-27	2000-10-25	Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23

Publications (1)

Publication Number	Publication Date
ATE284382T1 true ATE284382T1 (de)	2004-12-15

Family

ID=10863507

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00975954T ATE284382T1 (de)	1999-10-27	2000-10-25	Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23

Country Status (32)

Country	Link
US (2)	US6673965B1 (de)
EP (1)	EP1224164B1 (de)
JP (1)	JP3922431B2 (de)
KR (1)	KR20020044578A (de)
CN (1)	CN1182107C (de)
AR (1)	AR026244A1 (de)
AT (1)	ATE284382T1 (de)
AU (1)	AU766072B2 (de)
BR (1)	BR0015082A (de)
CA (1)	CA2389319A1 (de)
CO (1)	CO5261576A1 (de)
CZ (1)	CZ20021424A3 (de)
DE (1)	DE60016622T2 (de)
DK (1)	DK1224164T3 (de)
ES (1)	ES2233474T3 (de)
GB (1)	GB9925470D0 (de)
GC (1)	GC0000142A (de)
HK (1)	HK1049146A1 (de)
HU (1)	HUP0203270A3 (de)
IL (1)	IL149364A0 (de)
MX (1)	MXPA02004228A (de)
MY (1)	MY133601A (de)
NO (1)	NO20021965L (de)
NZ (1)	NZ518566A (de)
PE (1)	PE20010898A1 (de)
PL (1)	PL356524A1 (de)
PT (1)	PT1224164E (de)
SI (1)	SI1224164T1 (de)
TW (1)	TW561141B (de)
UY (1)	UY26416A1 (de)
WO (1)	WO2001030747A1 (de)
ZA (1)	ZA200203255B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2334636A2 (de) *	2008-09-19	2011-06-22	Pfizer Inc.	Als antibakterielle mittel geeignete hydroxaminsäurederivate
WO2011068853A2 (en)	2009-12-01	2011-06-09	Boston Medical Center Corporation	TREATMENT OF IgE-MEDIATED DISEASE
CA2782453C (en)	2009-12-16	2015-11-24	Matthew Frank Brown	N-linked hydroxamic acid derivatives useful as antibacterial agents
MX341977B (es)	2011-03-07	2016-09-07	Pfizer	Derivados de fluoro-piridinona utiles como agentes antibacterianos.
CA2830866A1 (en)	2011-04-08	2012-10-11	Pfizer Inc.	Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
CA2830920C (en)	2011-04-08	2015-07-14	Pfizer Inc.	Isoxazole derivatives useful as antibacterial agents
EP2525213A1 (de) *	2011-05-16	2012-11-21	Renishaw plc	Spektroskopievorrichtung und Verfahren zur Bestimmung der in einer Probe vorkommenden Komponenten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9513331D0 (en)	1995-06-30	1995-09-06	British Biotech Pharm	Matrix metalloproteinase inhibitors
GB9813451D0 (en) *	1998-06-22	1998-08-19	Smithkline Beecham Plc	Novel compounds

1999
- 1999-10-27 GB GBGB9925470.8A patent/GB9925470D0/en not_active Ceased
2000
- 2000-10-25 DE DE60016622T patent/DE60016622T2/de not_active Expired - Lifetime
- 2000-10-25 PT PT00975954T patent/PT1224164E/pt unknown
- 2000-10-25 MX MXPA02004228A patent/MXPA02004228A/es active IP Right Grant
- 2000-10-25 CN CNB008173680A patent/CN1182107C/zh not_active Expired - Fee Related
- 2000-10-25 US US10/111,209 patent/US6673965B1/en not_active Expired - Fee Related
- 2000-10-25 DK DK00975954T patent/DK1224164T3/da active
- 2000-10-25 NZ NZ518566A patent/NZ518566A/en unknown
- 2000-10-25 AR ARP000105622A patent/AR026244A1/es not_active Application Discontinuation
- 2000-10-25 ES ES00975954T patent/ES2233474T3/es not_active Expired - Lifetime
- 2000-10-25 BR BR0015082-7A patent/BR0015082A/pt not_active IP Right Cessation
- 2000-10-25 CA CA002389319A patent/CA2389319A1/en not_active Abandoned
- 2000-10-25 AU AU13895/01A patent/AU766072B2/en not_active Ceased
- 2000-10-25 IL IL14936400A patent/IL149364A0/xx unknown
- 2000-10-25 UY UY26416A patent/UY26416A1/es not_active Application Discontinuation
- 2000-10-25 SI SI200030603T patent/SI1224164T1/xx unknown
- 2000-10-25 AT AT00975954T patent/ATE284382T1/de not_active IP Right Cessation
- 2000-10-25 HU HU0203270A patent/HUP0203270A3/hu unknown
- 2000-10-25 CZ CZ20021424A patent/CZ20021424A3/cs unknown
- 2000-10-25 WO PCT/EP2000/010649 patent/WO2001030747A1/en active IP Right Grant
- 2000-10-25 PL PL00356524A patent/PL356524A1/xx unknown
- 2000-10-25 MY MYPI20005012A patent/MY133601A/en unknown
- 2000-10-25 JP JP2001533102A patent/JP3922431B2/ja not_active Expired - Fee Related
- 2000-10-25 GC GCP2000972 patent/GC0000142A/xx active
- 2000-10-25 EP EP00975954A patent/EP1224164B1/de not_active Expired - Lifetime
- 2000-10-25 KR KR1020027005340A patent/KR20020044578A/ko not_active Application Discontinuation
- 2000-10-26 CO CO00081571A patent/CO5261576A1/es not_active Application Discontinuation
- 2000-10-26 TW TW089122497A patent/TW561141B/zh active
- 2000-10-27 PE PE2000001156A patent/PE20010898A1/es not_active Application Discontinuation
2002
- 2002-04-24 ZA ZA200203255A patent/ZA200203255B/en unknown
- 2002-04-25 NO NO20021965A patent/NO20021965L/no unknown
- 2002-12-19 HK HK02109235A patent/HK1049146A1/xx not_active IP Right Cessation
2003
- 2003-10-03 US US10/678,679 patent/US20040077727A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60016622D1 (de)	2005-01-13
NO20021965L (no)	2002-06-13
MY133601A (en)	2007-11-30
MXPA02004228A (es)	2002-10-17
EP1224164A1 (de)	2002-07-24
WO2001030747A1 (en)	2001-05-03
SI1224164T1 (en)	2005-06-30
GB9925470D0 (en)	1999-12-29
BR0015082A (pt)	2003-04-15
NO20021965D0 (no)	2002-04-25
IL149364A0 (en)	2002-11-10
DE60016622T2 (de)	2005-11-03
PL356524A1 (en)	2004-06-28
UY26416A1 (es)	2001-05-31
HUP0203270A3 (en)	2003-11-28
CZ20021424A3 (cs)	2002-09-11
AU1389501A (en)	2001-05-08
GC0000142A (en)	2005-06-29
CO5261576A1 (es)	2003-03-31
CN1182107C (zh)	2004-12-29
PT1224164E (pt)	2005-04-29
US6673965B1 (en)	2004-01-06
JP3922431B2 (ja)	2007-05-30
ZA200203255B (en)	2003-03-20
NZ518566A (en)	2004-02-27
US20040077727A1 (en)	2004-04-22
PE20010898A1 (es)	2001-10-13
CN1411436A (zh)	2003-04-16
AR026244A1 (es)	2003-02-05
CA2389319A1 (en)	2001-05-03
HK1049146A1 (en)	2003-05-02
ES2233474T3 (es)	2005-06-16
AU766072B2 (en)	2003-10-09
HUP0203270A2 (hu)	2003-02-28
TW561141B (en)	2003-11-11
EP1224164B1 (de)	2004-12-08
KR20020044578A (ko)	2002-06-15
DK1224164T3 (da)	2005-03-29
JP2003512450A (ja)	2003-04-02

Legal Events

Date

Code

Title

Description

2005-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1224164

Country of ref document: EP

2007-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69820906D1 (de)	2004-02-05	Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren
NO20000877L (no)	2000-11-28	Forbedret syrekorrosjonsinhibitor
DE69906059D1 (de)	2003-04-24	Anthranilsäurederivate als inhibitoren der c-gmp-phosphodiesterase
IS7682A (is)	2005-02-01	Samsetning og andveiruvirkni skiptitengdra azaindóloxóediksýru píperazín afleiðna
IS6039A (is)	2001-08-07	Tálmi við súlfamatóhýdroxamsýrumálmprótínkljúfi
NO20006115L (no)	2001-02-07	Nytt 3-aryl-2-hydroksypropionsyrederivat (I)
ATE304997T1 (de)	2005-10-15	Derivate von beta-aminosäurenitrilen
DE69511240T2 (de)	1999-12-09	Derivate des hydroxamsäure als metalloproteinaseinhibitoren
DE50213681D1 (de)	2009-08-27	Wässrige Lösung von Ascorbinsäure
DE60043730D1 (de)	2010-03-11	Arylsulfonamid-substituierte hydroxamsäure-derivate
ATE269349T1 (de)	2004-07-15	Derivativen von monosacchariden als zelladhäsionshemmer
EE03745B1 (et)	2002-06-17	Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena
ATE284382T1 (de)	2004-12-15	Hydroxamsäurederivat als inhibitor der produktion von löslichem menschlichem cd23
DE60012303D1 (de)	2004-08-26	Alkinylische hydroxamsäureverbindungen als tace inhibitoren
DE60019507D1 (de)	2005-05-25	Wässrige Dispersionen von Percarbonsäure
AU6689900A (en)	2001-02-05	3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
DE60016264D1 (de)	2004-12-30	Direktmetallherstellung von teilen
NO20024481D0 (no)	2002-09-19	Difluorbutyrsyre metalloproteaseinhibitorer
ATE428691T1 (de)	2009-05-15	3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha
ATE269296T1 (de)	2004-07-15	Hydroxamsäure-derivate als inhibitoren der produktion von menschlichen cd23 und der freigabe von tnf
DK1228026T3 (da)	2004-04-05	15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
DE69706874T2 (de)	2002-03-28	Substituierte 4-arylbutyrsäurederivate als matrix metalloprotease inhibitoren
ATE227288T1 (de)	2002-11-15	Acetylenische ortho-sulfonamido- und phosphinsäure-amido-bicyclische heteroarylhydroxamsäure als tace-inhibitoren
ATE303995T1 (de)	2005-09-15	Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme- inhibitoren
GB0230240D0 (en)	2003-02-05	Removal of an acid